Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients.

Medicine (Baltimore) · 2020 · PMC7748176 · PMID 33371122

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The second endpoint, median OS, was months longer in maintenance group than in the observation group, but unfortunately this result did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.